Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Frontage Holdings (1521 HK)
Watchlist
59
Analysis
Health Care
•
China
Frontage Holdings Corporation operates as a biotechnology company. The Company offers clinical trials, bioequivalence studies, medical writing, and agrochemical services. Frontage Holdings serves customers in Hong Kong.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Joinn Laboratories China Lt
•
25 Feb 2021 17:41
JOINN Laboratories IPO: Trading Debut
The grey market price varies from HK$146.70-HK$142.00 per H-share vs listing price of HK$151. JOINN is fairly priced at the H-share listing price...
Arun George
Follow
360 Views
Share
bullish
•
Joinn Laboratories China Lt
•
17 Feb 2021 01:43
JOINN Laboratories IPO: Valuation Insights
JOINN has launched its HK IPO at an indicative price range of HK$133-151 per H-share. The combination of a reasonable AH discount and relative...
Arun George
Follow
399 Views
Share
bullish
•
Joinn Laboratories China Lt
•
15 Feb 2021 21:15
JOINN Laboratories IPO: Valuation First Look
JOINN is seeking to raise as much as $600 million through a HK IPO, according to press reports. In this note, we take a first look at the potential...
Arun George
Follow
977 Views
Share
bullish
•
Joinn Laboratories China Lt
•
09 Feb 2021 23:27
JOINN Laboratories IPO: PHIP Points to Progress
JOINN is seeking to raise as much as $600 million through an HK IPO. The PHIP which disclose the 9M20 results reinforce our view that JOINN has...
Arun George
Follow
323 Views
Share
bullish
•
Joinn Laboratories China Lt
•
07 Feb 2021 16:09
Joinn Lab (昭衍新药) A+H: Leader in the Niche Drug Safety CRO Segment
Investors would like to pay a premium for the company's strong leadership in the niche market and high growth ahead, but the premium will be offset...
Ke Yan, CFA, FRM
Follow
313 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.1
x